Valeant said that it would increase the amount of cash that it would pay by $10 a share, to $58.30 per Allergan share. It will also offered up to $25 a share in additional payouts, if Allergan’s Darpin treatment hits certain performance thresholds.
via NYT > Business Day http://ift.tt/1ot5UI4
via WordPress http://ift.tt/1ot7Gcc
No comments:
Post a Comment